Financial Information
Key Financial Highlights
As at 2026-09-30 · Unit: M.Baht
| Item | 2024 | 2025 | H1 2026 | 9M 2026 |
|---|---|---|---|---|
| Total revenue | 21,081 | 15,274 | 7,703 | 12,989 |
| Net profit | 1,664 | 697.59 | 574.3 | 1,020 |
| Total assets | 14,692 | 14,247 | 15,517 | 16,068 |
| Total liabilities | 3,659 | 3,767 | 4,225 | 4,376 |
| Shareholders' equity | 8,516 | 8,115 | 8,572 | 8,783 |
| EPS (Baht) | 3.17 | 1.33 | 1.09 | 1.94 |
| ROE (%) | 20.02 | 8.39 | 10.2 | 14.28 |
| ROA (%) | 29.65 | 12.15 | 13.64 | 19.99 |
| Net profit margin (%) | 12.78 | 6.91 | 11.93 | 12.8 |
| D/E (times) | 0.33 | 0.36 | 0.37 | 0.37 |
| Item | Y/E 2023Dec 2023 | Y/E 2024Dec 2024 | Y/E 2025Dec 2025 | 9M/2025Sep 2025 | 9M/2026Sep 2026 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 1,701.75 | 2,072.46 | 2,725.56 | 2,293.21 | 3,028.07 |
| A/R Net | 2,123.6 | 1,715.45 | 1,139.39 | 1,317.33 | 1,976.3 |
| Inventories | 570.02 | 392.01 | 396.09 | 606.24 | 773.09 |
| Current Assets | 8,632.78 | 8,768.54 | 7,712.58 | 8,036.07 | 9,011.7 |
| PP&E Net | 3,967.19 | 3,754.26 | 3,403.44 | 3,498.34 | 3,253.03 |
| Non-Current Assets | 6,199.23 | 5,923.56 | 6,534.74 | 6,036.8 | 7,056.08 |
| Total Assets | 14,832.01 | 14,692.1 | 14,247.32 | 14,072.88 | 16,067.77 |
| OD | 1,247.36 | 1,185.77 | 1,110.91 | 933.07 | 999.68 |
| A/P Net | 577.6 | 684.25 | 895.19 | 928.15 | 886.31 |
| Current portion of LT | 191.74 | 164.71 | 194.28 | 196.15 | 100.38 |
| Current Liabilities | 2,970.98 | 2,681.51 | 2,708.78 | 2,712.42 | 3,092.08 |
| Non-Current Liabilities | 1,191.09 | 977.34 | 1,057.82 | 1,005.32 | 1,284.35 |
| Total Liabilities | 4,162.08 | 3,658.85 | 3,766.6 | 3,717.73 | 4,376.43 |
| Authorized Capital | 525 | 525 | 525 | 525 | 525 |
| Paid-Up Capital | 525 | 525 | 525 | 525 | 525 |
| Premium (Discount) on Share Capital | 680.4 | 680.4 | 680.4 | 680.4 | 680.4 |
| Retained Earnings (Deficit) | 6,740.47 | 7,196.22 | 6,994.17 | 6,822.18 | 7,488.83 |
| Treasury Stock | — | — | — | — | — |
| Shares Of The Company Held By Subsidiaries | — | — | — | — | — |
| Other Components Of Equity | 160.64 | 114.76 | -84.07 | -23.99 | 88.51 |
| - Surplus (Deficits) | — | — | — | — | — |
| Shareholders' Equity | 8,106.51 | 8,516.38 | 8,115.5 | 8,003.59 | 8,782.75 |
| Minority Interest | 2,563.42 | 2,516.87 | 2,365.22 | 2,351.55 | 2,908.6 |
Detailed Latest Statements
Q3/2026 * · Consolidate · Reviewed · Unit: M.Baht
| Current Assets | |
| Cash And Cash Equivalents | 3,028.07 |
| Trade And Other Receivables - Current - Net | 1,976.3 |
| Inventories - Net | 773.09 |
| Other Current Financial Assets | 394.48 |
| Other Current Financial Assets - Others | 394.48 |
| Income Tax Receivable - Current | 970.72 |
| Other Tax Or Other Receivables Under Law And Regulations - Current | 1,465.94 |
| Other Tax Receivables | 1,465.94 |
| Other Current Assets | 403.1 |
| Advance Payment For Purchases Of Assets | 0 |
| Other Current Assets - Others | 403.1 |
| Total Current Assets | 9,011.7 |
| Non-Current Assets | |
| Restricted Deposits - Non-Current | 511.43 |
| Investment In Subsidiaries, Associates And Joint Ventures Using The Equity Method - Net | 629.81 |
| Investment In Associates | 629.81 |
| Other Non-Current Financial Assets | 7.33 |
| Deposits | 7.33 |
| Biological Assets - Non-Current | 27.9 |
| Investment Properties - Net | 43.87 |
| Property, Plant And Equipment - Net | 3,253.03 |
| Right-Of-Use Assets - Net | 60.61 |
| Intangible Assets - Net | 202.78 |
| Intangible Assets - Others | 202.78 |
| Goodwill - Net | 186 |
| Deferred Tax Assets | 18.55 |
| Other Non-Current Assets | 2,114.77 |
| Other Non-Current Assets - Others | 2,114.77 |
| Total Non-Current Assets | 7,056.08 |
| Total Assets | 16,067.77 |
| Current Liabilities | |
| Bank Overdrafts And Short-Term Borrowings From Financial Institutions | 999.68 |
| Trade And Other Payables - Current | 886.31 |
| Accrued Expenses - Current | 662.81 |
| Current Portion Of Long-Term Debts | 100.38 |
| Financial Institutions | 100.38 |
| Other Current Financial Liabilities | 68.84 |
| Retentions | 68.84 |
| Current Portion Of Lease Liabilities | 24.11 |
| Income Tax Payable | 155.43 |
| Other Current Liabilities | 194.53 |
| Total Current Liabilities | 3,092.08 |
| Non-Current Liabilities | |
| Non-Current Portion Of Long-Term Debts | 100.56 |
| Financial Institutions | 100.56 |
| Non-Current Portion Of Lease Liabilities | 38.92 |
| Long-Term Provisions | 188.88 |
| Provisions For Employee Benefit Obligations - Non-Current | 216.79 |
| Deferred Tax Liabilities | 739.2 |
| Total Non-Current Liabilities | 1,284.35 |
| Total Liabilities | 4,376.43 |
| Authorised Share Capital | 525 |
| Authorised Ordinary Shares | 525 |
| Issued And Paid-Up Share Capital | 525 |
| Paid-Up Ordinary Shares | 525 |
| Premium (Discount) On Share Capital | 680.4 |
| Premium (Discount) On Ordinary Shares | 680.4 |
| Retained Earnings (Deficits) | 7,488.83 |
| Retained Earnings - Appropriated | 1,363.1 |
| Legal And Statutory Reserves | 52.5 |
| Other Reserves | 1,310.6 |
| Retained Earnings (Deficits) - Unappropriated | 6,125.73 |
| Other Components Of Equity | 88.51 |
| Currency Translation Adjustments | 88.51 |
| Equity Attributable To Owners Of The Parent | 8,782.75 |
| Non-Controlling Interests | 2,908.6 |
| Total Equity | 11,691.34 |
| Total Liabilities And Equity | 16,067.77 |
Auditor's Reports
| Report | Date of submission | Auditor’s opinion | Auditor’s firm |
|---|---|---|---|
| Q3 /2026 | 9 Nov 2026 | Unqualified opinion | EY OFFICE LIMITED |
| Q2 /2026 | 4 Aug 2026 | Unqualified opinion | EY OFFICE LIMITED |
| Q1 /2026 | 7 May 2026 | Unqualified opinion | EY OFFICE LIMITED |
| Yearly 2025 | 16 Feb 2026 | Unqualified opinion | EY OFFICE LIMITED |
| Q3 /2025 | 5 Nov 2025 | Unqualified opinion | EY OFFICE LIMITED |

